MENU Quick Go

  • HOME
  • Invest Relations
  • Corporate Value
Corporate Value

PharmAbcine is a biotech company that develops fully human therapeutic antibodies using innovative discovery technology for the treatment of cancer.

The innovation of PharmAbcine compared to existing antibody companies, lies in

  • Established fully human antibody libraries with the best quality.
  • Established comprehensive and efficient selection system to build competitive pipelines.
  • Novel platform technology for the next generation of therapeutic antibodies.
  • Established Glioblastoma Cancer Stem Cell Libraries derived from patients and animal models to discover novel therapeutic antibody against cancer stem cell.